Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

SUVEN PHARMACEUTICALS LTD.

NSE : SUVENPHARBSE : 543064ISIN CODE : INE03QK01018Industry : Pharmaceuticals & DrugsHouse : Private

BSE1108.2552.7 (+4.99 %)

PREV CLOSE ( ) 1055.55

OPEN PRICE ( ) 1046.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 8737

TODAY'S LOW / HIGH ( )1046.00 1146.15

52 WK LOW / HIGH ( )586.1 1359

NSE1104.9050.15 (+4.75 %)

PREV CLOSE( ) 1054.75

OPEN PRICE ( ) 1056.95

BID PRICE (QTY) 1104.90 (23)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 154325

TODAY'S LOW / HIGH( ) 1053.65 1147.10

52 WK LOW / HIGH ( )585.2 1360

Quarters

Select year

( in Million)

Particulars

Sep 2024

Jun 2024

Mar 2024

Dec 2023

Audited / UnAudited

UnAudited

Net Sales

2577.2

2306.9

2529.3

2198.2

Total Expenditure

1537.1

1507.6

1795.86

1546.75

PBIDT (Excl OI)

1040.1

799.3

733.44

651.45

Other Income

141.2

181.6

170.54

143.45

Operating Profit

1181.3

980.9

903.98

794.89

Interest

16.7

12.69

Exceptional Items

PBDT

1164.6

964.9

880.98

782.2

Depreciation

169.6

134

172.46

127.52

Profit Before Tax

995

830.9

708.52

654.68

Tax

175.2

223.2

174.79

187.15

Provisions and contingencies

Profit After Tax

819.8

607.7

533.73

467.53

Extraordinary Items

Prior Period Expenses

Other Adjustments

Net Profit

819.8

607.7

533.73

467.53

Minority Interest

2.3

Shares of Associates

Other related items

Misc. Expenses Written off

Consolidated Net Profit

822.1

607.7

533.73

467.54

Equity Capital

254.6

254.57

Face Value (IN RS)

Reserves

Calculated EPS

3.22

2.38

2.09

1.83

Calculated EPS (Annualised)

12.91

9.54

8.38

7.34

No of Public Share Holdings

127025364

101822407

% of Public Share Holdings

49.9

PBIDTM% (Excl OI)

40.35

34.64

28.99

29.63

PBIDTM%

45.83

42.52

35.74

36.16

PBDTM%

45.18

41.82

34.83

35.58

PBTM%

38.60

36.01

28.01

29.78

PATM%

31.80

26.34

21.10

21.26

Notes

Risk Disclosures on Derivatives

Quarterly Results

SUVEN PHARMACEUTICALS LTD.